Altered levels of cerebrospinal fluid reelin in frontotemporal dementia and Alzheimer's disease

被引:61
作者
Sáez-Valero, J
Costell, M
Sjögren, M
Andreasen, N
Blennow, K
Luque, JM
机构
[1] Univ Miguel Hernandez, CSIC, Inst Neurociencias, E-03550 Alicante, Spain
[2] Univ Valencia, Dept Bioquim & Biol Mol, Valencia, Spain
[3] Univ Gothenburg, Sahlgrens Univ Hosp, Dept Clin Neurosci, Molndal, Sweden
[4] Karolinska Inst, NEUROTEC, Dept Clin Geriatr, Stockholm, Sweden
关键词
neurodegeneration; CSF; AD; FTD; biomarker;
D O I
10.1002/jnr.10554
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Reelin is an essential glycoprotein for correct cytoarchitectonic organization during CNS development. Its function in the adult brain is far less well understood, but altered brain and blood reelin levels have been reported in some psychiatric disorders, and the possibility has been considered of an involvement of the reelin signaling pathway in neurodegeneration. Here we report, for the first time, the presence of detectable levels of reelin in rat and human cerebrospinal fluid (CSF) and show evidence for the involvement of a 180-kDa reelin fragment in two neurodegenerative disorders. This fragment was analyzed by Western blotting in CSF samples from 13 healthy control individuals and 14 frontotemporal dementia (FTD) and 20 Alzheimer's disease (AD) patients. Increased CSF 180-kDa reelin was found in FTD (161.7 +/- 6.7 arbitrary units; a.u.) and AD (151.4 +/- 3.8 a.u.) compared with control individuals (141.4 +/- 1.2 a.u., P < 0.05). Our results strongly suggest the involvement of reelin signaling in neurodegenerative pathologies. (C) 2003 Wiley-Liss, Inc.
引用
收藏
页码:132 / 136
页数:5
相关论文
共 35 条
  • [1] Evaluation of CSF-tau and CSF-Aβ42 as diagnostic markers for Alzheimer disease in clinical practice
    Andreasen, N
    Minthon, L
    Davidsson, P
    Vanmechelen, E
    Vanderstichele, H
    Winblad, B
    Blennow, K
    [J]. ARCHIVES OF NEUROLOGY, 2001, 58 (03) : 373 - 379
  • [2] BEFFERT U, 2002, REELIN MEDIATED ACTI
  • [3] BRUN A, 1994, J NEUROL NEUROSUR PS, V57, P416
  • [4] Reelin is a ligand for lipoprotein receptors
    D'Arcangelo, G
    Homayouni, R
    Keshvara, L
    Rice, DS
    Sheldon, M
    Curran, T
    [J]. NEURON, 1999, 24 (02) : 471 - 479
  • [5] Reelin is a secreted glycoprotein recognized by the CR-50 monoclonal antibody
    DArcangelo, G
    Nakajima, K
    Miyata, T
    Ogawa, M
    Mikoshiba, K
    Curran, T
    [J]. JOURNAL OF NEUROSCIENCE, 1997, 17 (01) : 23 - 31
  • [6] A panel of monoclonal antibodies against reelin, the extracellular matrix protein defective in reeler mutant mice
    de Bergeyck, V
    Naerhuyzen, B
    Goffinet, AM
    de Rouvroit, CL
    [J]. JOURNAL OF NEUROSCIENCE METHODS, 1998, 82 (01) : 17 - 24
  • [7] Reduction in Reelin immunoreactivity in hippocampus of subjects with schizophrenia, bipolar disorder and major depression
    Fatemi, SH
    Earle, JA
    McMenomy, T
    [J]. MOLECULAR PSYCHIATRY, 2000, 5 (06) : 654 - 663
  • [8] Altered levels of Reelin and its isoforms in schizophrenia and mood disorders
    Fatemi, SH
    Kroll, JL
    Stary, JM
    [J]. NEUROREPORT, 2001, 12 (15) : 3209 - 3215
  • [9] PHOSPHORYLATION OF TAU IN APOLIPOPROTEIN E-DEFICIENT MICE
    GENIS, I
    GORDON, I
    SEHAYEK, E
    MICHAELSON, DM
    [J]. NEUROSCIENCE LETTERS, 1995, 199 (01) : 5 - 8
  • [10] Apolipoprotein-E genotyping in Alzheimer's disease and frontotemporal dementia
    Gustafson, L
    Abrahamson, M
    Grubb, A
    Nilsson, K
    Fex, G
    [J]. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 1997, 8 (04) : 240 - 243